Studo of Morphology and Drug Release based on Poly(N-isopropylacrylamide)/Montmorillonite Nanocomposites

碩士 === 國立臺灣大學 === 材料科學與工程學研究所 === 95 === PNIPAAm, PNIPAAm-AAm copymer and their nanocomposites with MMT were successfully fabricated by emulsifier-free emulsion polymerization. The exfoliated morphology was confirmed by the TEM microscopy and X-ray diffraction patterns. The LCST would be increased b...

Full description

Bibliographic Details
Main Authors: Ming-Huei Yen, 顏銘翬
Other Authors: King-Fu Lin
Format: Others
Language:en_US
Published: 2007
Online Access:http://ndltd.ncl.edu.tw/handle/38065674782540519202
id ndltd-TW-095NTU05159036
record_format oai_dc
spelling ndltd-TW-095NTU051590362015-12-07T04:04:12Z http://ndltd.ncl.edu.tw/handle/38065674782540519202 Studo of Morphology and Drug Release based on Poly(N-isopropylacrylamide)/Montmorillonite Nanocomposites 聚氮異丙基丙烯醯胺/蒙脫石奈米複合物之型態與其在藥物釋放系統之應用 Ming-Huei Yen 顏銘翬 碩士 國立臺灣大學 材料科學與工程學研究所 95 PNIPAAm, PNIPAAm-AAm copymer and their nanocomposites with MMT were successfully fabricated by emulsifier-free emulsion polymerization. The exfoliated morphology was confirmed by the TEM microscopy and X-ray diffraction patterns. The LCST would be increased by adding MMT in the PNIPAAm series slightly, but decreased in PNIPAAm-AAm series. Besides, MMT indeed influenced the rate of phase transformation. Due to the change of morphology, the changes of physical properties were expected. The visible light absorption of PNIPAAm-AAm nanocomposite films was increased with the MMT content. This was due to the fact that the visible light would be scattered by MMT nanoplatelets. Molecular weight was also decreased in the presence of MMT. In PNIPAAm-AAm copolymer series, the glassy transition temperature was increased with the MMT content due to the molecular chains were trapped by nanoplatelets. However, in PNIPAAm series, a reverse result was observed. This may be due to that the presence of MMT might interfere with the formation of hydrogen bonding. Furthermore, we applied these new materials to drug delivery system. From the toxicity measurement, only PNIPAAm-AAm series had a trace of toxicity, but the toxicity could be diminished in the presence of MMT. PNIPAAm and PNIPAAm-AAm-GMA were innocuous to yeast. In order to maintain the shape of nanocomposite films in water, crosslinked PNIPAAm-AAm-GMA series were adopted for the drug releasing and swelling ratio experiments. The rate of drug releasing and the diffusion coefficient were decreased with the MMT content, because the presence of MMT nanoplatelets in the matrix could provide the tortuosity to the diffusion path. In the swelling experiment, the swelling ratio increased with the content of MMT. However, with higher MMT content, the specimens were more sustainable in the water. King-Fu Lin 林金福 2007 學位論文 ; thesis 76 en_US
collection NDLTD
language en_US
format Others
sources NDLTD
description 碩士 === 國立臺灣大學 === 材料科學與工程學研究所 === 95 === PNIPAAm, PNIPAAm-AAm copymer and their nanocomposites with MMT were successfully fabricated by emulsifier-free emulsion polymerization. The exfoliated morphology was confirmed by the TEM microscopy and X-ray diffraction patterns. The LCST would be increased by adding MMT in the PNIPAAm series slightly, but decreased in PNIPAAm-AAm series. Besides, MMT indeed influenced the rate of phase transformation. Due to the change of morphology, the changes of physical properties were expected. The visible light absorption of PNIPAAm-AAm nanocomposite films was increased with the MMT content. This was due to the fact that the visible light would be scattered by MMT nanoplatelets. Molecular weight was also decreased in the presence of MMT. In PNIPAAm-AAm copolymer series, the glassy transition temperature was increased with the MMT content due to the molecular chains were trapped by nanoplatelets. However, in PNIPAAm series, a reverse result was observed. This may be due to that the presence of MMT might interfere with the formation of hydrogen bonding. Furthermore, we applied these new materials to drug delivery system. From the toxicity measurement, only PNIPAAm-AAm series had a trace of toxicity, but the toxicity could be diminished in the presence of MMT. PNIPAAm and PNIPAAm-AAm-GMA were innocuous to yeast. In order to maintain the shape of nanocomposite films in water, crosslinked PNIPAAm-AAm-GMA series were adopted for the drug releasing and swelling ratio experiments. The rate of drug releasing and the diffusion coefficient were decreased with the MMT content, because the presence of MMT nanoplatelets in the matrix could provide the tortuosity to the diffusion path. In the swelling experiment, the swelling ratio increased with the content of MMT. However, with higher MMT content, the specimens were more sustainable in the water.
author2 King-Fu Lin
author_facet King-Fu Lin
Ming-Huei Yen
顏銘翬
author Ming-Huei Yen
顏銘翬
spellingShingle Ming-Huei Yen
顏銘翬
Studo of Morphology and Drug Release based on Poly(N-isopropylacrylamide)/Montmorillonite Nanocomposites
author_sort Ming-Huei Yen
title Studo of Morphology and Drug Release based on Poly(N-isopropylacrylamide)/Montmorillonite Nanocomposites
title_short Studo of Morphology and Drug Release based on Poly(N-isopropylacrylamide)/Montmorillonite Nanocomposites
title_full Studo of Morphology and Drug Release based on Poly(N-isopropylacrylamide)/Montmorillonite Nanocomposites
title_fullStr Studo of Morphology and Drug Release based on Poly(N-isopropylacrylamide)/Montmorillonite Nanocomposites
title_full_unstemmed Studo of Morphology and Drug Release based on Poly(N-isopropylacrylamide)/Montmorillonite Nanocomposites
title_sort studo of morphology and drug release based on poly(n-isopropylacrylamide)/montmorillonite nanocomposites
publishDate 2007
url http://ndltd.ncl.edu.tw/handle/38065674782540519202
work_keys_str_mv AT minghueiyen studoofmorphologyanddrugreleasebasedonpolynisopropylacrylamidemontmorillonitenanocomposites
AT yánmínghuī studoofmorphologyanddrugreleasebasedonpolynisopropylacrylamidemontmorillonitenanocomposites
AT minghueiyen jùdànyìbǐngjībǐngxīxīànméngtuōshínàimǐfùhéwùzhīxíngtàiyǔqízàiyàowùshìfàngxìtǒngzhīyīngyòng
AT yánmínghuī jùdànyìbǐngjībǐngxīxīànméngtuōshínàimǐfùhéwùzhīxíngtàiyǔqízàiyàowùshìfàngxìtǒngzhīyīngyòng
_version_ 1718146229667364864